These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32198722)

  • 1. Efficacy of a new nutraceutical formulation (CHETOGERD
    Fiorini G; Saracino IM; Pavoni M; Saccomanno L; Vaira D
    Intern Emerg Med; 2020 Oct; 15(7):1265-1269. PubMed ID: 32198722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
    Winter JW; Heading RC
    Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of esophagogastric junction contractile index in patients with gastroesophageal reflux disease or functional heartburn].
    Wang K; Duan LP; Ge Y; Xia ZW; Xu ZJ
    Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):283-8. PubMed ID: 27030616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonerosive reflux disease.
    Long JD; Orlando RC
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease.
    Zheng YM; Chen XY; Cai JY; Yuan Y; Xie WR; Xu JT; Xia HH; Zhang M; He XX; Wu LH
    World J Gastroenterol; 2021 Feb; 27(6):513-522. PubMed ID: 33642825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease.
    Gold BD; Pilmer B; Kierkuś J; Hunt B; Perez MC; Gremse D
    Dig Dis Sci; 2017 Nov; 62(11):3059-3068. PubMed ID: 28916953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heartburn sensation in nonerosive reflux disease: pattern of superficial sensory nerves expressing TRPV1 and epithelial cells expressing ASIC3 receptors.
    Ustaoglu A; Sawada A; Lee C; Lei WY; Chen CL; Hackett R; Sifrim D; Peiris M; Woodland P
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G804-G815. PubMed ID: 33655767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.
    Manabe N; Haruma K; Ito M; Takahashi N; Takasugi H; Wada Y; Nakata H; Katoh T; Miyamoto M; Tanaka S
    Dis Esophagus; 2012 Jul; 25(5):373-80. PubMed ID: 22050449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of gastroesophageal reflux in relation to symptom onset in patients with proton pump inhibitor-refractory nonerosive reflux disease accompanied by an underlying esophageal motor disorder.
    Izawa S; Funaki Y; Iida A; Tokudome K; Tamura Y; Ogasawara N; Sasaki M; Kasugai K
    Digestion; 2014; 89(1):61-7. PubMed ID: 24458115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Between GERD and NERD: the relevance of weakly acidic reflux.
    de Bortoli N; Ottonello A; Zerbib F; Sifrim D; Gyawali CP; Savarino E
    Ann N Y Acad Sci; 2016 Sep; 1380(1):218-229. PubMed ID: 27472432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis.
    Wu JC; Cheung CM; Wong VW; Sung JJ
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):690-5. PubMed ID: 17481961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.
    Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):612-9. PubMed ID: 22343515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.
    Karkon Varnosfaderani S; Hashem-Dabaghian F; Amin G; Bozorgi M; Heydarirad G; Nazem E; Nasiri Toosi M; Mosavat SH
    J Integr Med; 2018 Mar; 16(2):126-131. PubMed ID: 29526236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
    Lee KJ; Kwon HC; Cheong JY; Cho SW
    Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux.
    Zimmerman J; Hershcovici T
    J Clin Gastroenterol; 2008 Mar; 42(3):261-5. PubMed ID: 18223499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of proton pump inhibitors in nonerosive reflux disease.
    Dean BB; Gano AD; Knight K; Ofman JJ; Fass R
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):656-64. PubMed ID: 15290657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
    Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
    Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease.
    Woodland P; Shen Ooi JL; Grassi F; Nikaki K; Lee C; Evans JA; Koukias N; Triantos C; McDonald SA; Peiris M; Aktar R; Blackshaw LA; Sifrim D
    Gastroenterology; 2017 Nov; 153(5):1230-1239. PubMed ID: 28734832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.